跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“Guardant360”
全部
13
临床试验
6
药物
0
机构
0
资讯
7
去年
Guardant Health Launches First Tissue Test with Comprehensive Multiomic Analysis for Cancer Profiling
9个月前
Guardant Health Japan Secures First ESR1 Mutation Liquid Biopsy Approval for Breast Cancer Treatment Selection
6个月前
Guardant Health Advances Multi-Product Growth Strategy with Quest Partnership and FDA Milestones
去年
Two Phase III Trials Target Advanced Breast Cancer with Novel Therapeutic Approaches
9天前
FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutant HR-Positive/HER2-Negative Breast Cancer, Four Months After Advisers Voted No
去年
ctDNA Testing Shows Promise in Guiding Breast Cancer Treatment Decisions
7天前
AstraZeneca's Etcamah Misses Primary PFS Endpoint in Phase III SERENA-4 First-Line Breast Cancer Trial